Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$410K Sell
14,852
-295,948
-95% -$6.54M ﹤0.01% 2595
2026
Q1
$4.54M Buy
310,800
+284,241
+1,070% +$4.17M ﹤0.01% 1351
2025
Q4
$336K Sell
26,559
-154,890
-85% -$2.28M ﹤0.01% 2407
2025
Q3
$2.79M Sell
181,449
-271,762
-60% -$4.38M ﹤0.01% 1457
2025
Q2
$7.12M Buy
+453,211
New +$6.87M 0.01% 979
2024
Q4
Sell
-19,091
Closed -$535K 2947
2024
Q3
$535K Sell
19,091
-49,364
-72% -$1.39M ﹤0.01% 1901
2024
Q2
$1.79M Buy
+68,455
New +$1.42M ﹤0.01% 1432
2023
Q4
Sell
-153,423
Closed -$3.03M 2554
2023
Q3
$3.03M Buy
153,423
+142,544
+1,310% +$2.81M 0.01% 1049
2023
Q2
$247K Sell
10,879
-92,515
-89% -$1.86M ﹤0.01% 2193
2023
Q1
$2.03M Sell
103,394
-47,604
-32% -$914K ﹤0.01% 1453
2022
Q4
$2.6M Buy
+150,998
New +$2.68M 0.01% 1585

Other funds holding RXO

Marshall Wace's RXO Position: Q2 2026 in Review

Marshall Wace reduced its RXO (RXO) stake by 95% in Q2 2026, selling an estimated $6.54M and leaving 14,852 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #2595.

Marshall Wace first reported a position in RXO in Q4 2022 and has held it in 11 quarters since. The position peaked at $7.12M in Q2 2025. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Marshall Wace held 14,852 shares of RXO worth $410K as of Q2 2026.
  • Marshall Wace sold 295,948 RXO shares in Q2 2026, an estimated $6.54M.
  • RXO made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2595 holding.
  • Marshall Wace first reported a position in RXO in Q4 2022 and has held it in 11 quarters since.
  • Marshall Wace's RXO position peaked at $7.12M in Q2 2025.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.